Vice President, Medical Affairs-Ophthalmology

Responsibilities

• Provide deep medical and scientific expertise on medical affairs, launch, and lifecycle strategies
• Lead the development and implementation of Global medical strategy across Medical Affairs Operations and Medical Science Liaison functions
• Partner with the organization to establish market access strategies including pricing, reimbursement, and access
• Establish strategic partnerships with internal leaders in clinical development, regulatory affairs, safety, and commercial
• Grow professional relationships with the external expert community to maintain knowledge of disease areas and unmet medical needs
• Enrich relationships with patients and patient advocacy groups for clinical trials and commercial planning
• Represent Annexon at advisory boards, clinical investigator meetings, congresses, and symposia
• Collaborate with legal, compliance, and regulatory authorities to ensure ethical interactions with external stakeholders

Requirements

• Advanced degree (MD, PhD, or PharmD) preferred
• Minimum of 15 years Medical Affairs experience in biopharma
• Prior experience in ophthalmology product launches
• Established network of medical and clinical contacts
• Proven ability to lead and manage in a multi-functional matrix environment
• Experience in global, regional, or local healthcare ecosystems
• Knowledge of Good Clinical Practices (GCP) and international regulatory requirements
• Experience in finance, budgeting, and resource management
• Strong medical/clinical communication and presentation skills

Benefits

• Flexible work schedules and remote opportunities
• Shuttle service from BART, CalTrain, and the Ferry
• Competitive base salary and equity participation
• Employee stock purchase plan
• Comprehensive health benefits including medical, dental, and vision
• 401(k) and flexible spending plans

About the Company

Annexon Biosciences is a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye.